Lyme disease, persistent symptoms and the nervous system
Chronic Lyme disease and PTLDS: persistent symptoms and support
Lyme disease is a bacterial infection transmitted through the bite of an infected tick. The tick species and Borrelia bacteria involved can vary between regions. Most people improve after appropriate antibiotic treatment, but some continue to experience fatigue, pain, difficulty thinking and other symptoms for months or longer.1
The phrase “chronic Lyme disease” is used in several different ways. It may refer to untreated or late Lyme disease, persistent symptoms after treatment, or symptoms attributed to Lyme disease without a clearly documented previous infection.
When symptoms continue after recognised Lyme disease has been treated, healthcare professionals may use terms including post-treatment Lyme disease syndrome (PTLDS) and prolonged symptoms associated with Lyme disease.
The symptoms are real and can be deeply disruptive. This page explains the terminology, signs, diagnosis, treatment and where neuroplasticity-based nervous-system support may fit alongside appropriate medical care.
Understanding the terminology
One phrase can describe several different experiences
“Chronic Lyme disease” does not have one universally agreed clinical definition. That can make conversations about diagnosis, treatment and persistent symptoms confusing.
Lyme disease
A bacterial infection transmitted through the bite of an infected tick. Recommended assessment and treatment depend on symptoms, stage of infection, exposure history and regional clinical guidance. 1 , 7 , 8
Late or disseminated Lyme disease
Untreated or delayed Lyme disease can affect the joints, heart or nervous system. This is different from experiencing nonspecific symptoms after recommended treatment has been completed. 2 , 7 , 8
Post-treatment Lyme disease syndrome (PTLDS)
A term used for prolonged symptoms such as fatigue, pain and difficulty thinking that continue after recommended treatment for Lyme disease. Its cause is not fully understood, and the term does not establish that an active infection remains. 4 , 6 , 9 – 11
Chronic Lyme disease
A broad phrase used in different ways by patients, practitioners and organisations. It does not have one universally agreed clinical definition, so careful assessment should consider the original diagnosis, treatment history, current symptoms and other possible explanations.
The symptoms are real
Uncertainty about terminology or cause does not make persistent fatigue, pain, brain fog or other symptoms imaginary. People deserve to be heard and supported while the full picture is assessed.
From tick bite to infection
Lyme disease begins with an infected tick
Lyme disease is caused by Borrelia bacteria. In the United States, it is usually transmitted by infected blacklegged ticks. Other Borrelia species and tick populations are relevant in different parts of the world.1, 7, 8
Transmission generally becomes more likely the longer an infected tick remains attached. Prompt removal reduces the chance of infection, although individual circumstances vary.1
Lyme disease is not spread through ordinary contact. Current CDC information states that there is no evidence of transmission through touching, kissing or sexual contact.15
Possible spread if untreated
A simplified overview, not a diagnostic timeline.
re-origin supports members worldwide. Tick species, exposure patterns, testing procedures and clinical guidance vary by country, so people should follow advice from an appropriately qualified healthcare professional in their location.
What people may notice
Lyme disease can affect more than one part of the body
Symptoms vary according to the stage of infection. Not everyone notices a tick bite, and an erythema migrans rash does not always have the classic “bull’s-eye” appearance.2, 7, 8
Early flu-like symptoms
Fever, chills, headache, fatigue, muscle aches or swollen lymph nodes may occur.
Erythema migrans rash
An expanding red or discoloured rash can appear at the bite site or elsewhere. It may be warm but is not usually painful or itchy.
Facial weakness
Facial palsy can affect one or both sides of the face.
Joint symptoms
Lyme arthritis can cause significant pain and swelling, often affecting a large joint.
Neurological symptoms
Some people experience nerve pain, numbness, tingling, meningitis-related symptoms or other neurological effects.
Heart-related symptoms
Lyme carditis can affect heart rhythm and requires prompt medical assessment.
Seek medical assessment promptly
New facial weakness, fainting, chest pain, significant palpitations, shortness of breath, severe headache, neck stiffness or neurological changes need timely medical attention.
When recovery takes longer
Some symptoms can continue after treatment
Most people recover following recommended antibiotic treatment. A smaller group report prolonged symptoms that may affect daily function for months or longer. Estimates vary according to the definition used, the population studied and how symptoms are measured.4, 6, 9–11
Fatigue and reduced stamina
Energy may feel limited or inconsistent, and ordinary activities may require more recovery.
Pain and body aches
Muscle, joint or widespread pain may continue or fluctuate.
Brain fog
People may describe slower processing, memory problems, word-finding difficulty or reduced concentration.
Sleep disturbance
Sleep may become disrupted or feel unrefreshing.
Headaches and dizziness
Some people report recurrent headaches, light-headedness or a sense of disequilibrium.
Emotional impact
Living with persistent and poorly understood symptoms can affect mood, confidence, relationships and quality of life.
These symptoms are not specific to Lyme disease and can have several possible causes. Their presence alone cannot confirm ongoing infection or PTLDS.
Related reading: brain fog and cognitive fatigue, chronic fatigue and ME/CFS, chronic pain and sleep difficulties.
What research currently shows
There is no single established explanation
Researchers are still investigating why some people experience prolonged symptoms after Lyme disease treatment.
Possible areas of research include immune and inflammatory changes, tissue injury, altered neurological processing, post-infectious mechanisms and the interaction between the original illness and other health conditions.4–6, 9–11
Persistent symptoms do not automatically establish that an active infection remains. At the same time, reinfection, treatment failure, organ involvement and other medical conditions need to be considered when clinically relevant.
Post-infectious changes
The body may take time to settle after an infection, even when the original bacteria are no longer causing active disease.
Effects of the original illness
Inflammation or injury affecting joints, nerves or other tissues may take time to resolve.
Overlapping conditions
Sleep disorders, anaemia, thyroid conditions, medication effects, autoimmune illness, POTS, ME/CFS and other conditions can produce overlapping symptoms.
Nervous-system responses
Persistent pain, fatigue, uncertainty and repeated symptom flares can influence how the nervous system processes sensations and responds to stress.
No single explanation fits everyone. A person may have more than one contributing factor at the same time.
Getting the full picture
Testing has strengths and limitations
Lyme disease is assessed using exposure history, symptoms, physical findings and recommended laboratory testing when appropriate.3, 7, 8
An erythema migrans rash can support a clinical diagnosis without waiting for blood-test results. In people without the characteristic rash, recommended testing normally uses a two-step antibody-testing process.3, 7, 8
Antibody tests can be negative during the first few weeks of infection. They can also remain positive for months or years after treatment, so a positive result does not necessarily show whether an infection is currently active.3
There is no single blood test, scan or questionnaire that independently confirms PTLDS or explains every case of persistent symptoms.
A clinician may consider
- previous tick exposure;
- the original Lyme disease diagnosis;
- timing and type of antibiotic treatment;
- current symptoms and functional impact;
- new exposure or possible reinfection;
- objective neurological, cardiac or joint findings;
- medication effects;
- other infectious and non-infectious conditions;
- sleep, pain, autonomic and mental-health symptoms;
- whether specialist assessment is needed.
New or changing symptoms deserve assessment
Do not automatically assume that every new symptom is part of Lyme disease, PTLDS or nervous-system sensitisation.
Support depends on the clinical picture
Different situations require different approaches
Active Lyme disease is treated with antibiotics selected by a qualified healthcare professional according to the symptoms, stage of infection, age, pregnancy status, allergies and local clinical guidance.5, 7, 8
When symptoms continue after recommended treatment, the next step is usually to review the diagnosis, treatment history, possible reinfection, objective complications and other explanations.
Medical reassessment
Review whether there is evidence of active infection, reinfection, treatment failure, neurological involvement, carditis, arthritis or another condition.
Symptom-specific support
Pain, sleep disturbance, dizziness, fatigue, mood and cognitive symptoms may each need their own practical or medical support.
Rehabilitation adapted to capacity
Physical or occupational rehabilitation may be appropriate for some people but should reflect the person’s symptoms, health, function and tolerance.
Emotional and social support
Persistent symptoms can be isolating. Psychological or peer support can help people cope with uncertainty and disruption without suggesting that symptoms are imaginary.
Additional antibiotics are not automatically the answer
Some major clinical guidelines recommend against additional antibiotic treatment for nonspecific persistent symptoms when there is no objective evidence of reinfection or treatment failure. Clinical trials have not demonstrated sustained overall benefit from prolonged courses and have identified possible harms. Decisions about testing or treatment should always be made with an appropriately qualified healthcare professional.4–8, 12–14
This does not mean the symptoms are unimportant. It means support may need to address the individual symptom pattern and wider clinical picture.
A wider nervous-system picture
Persistent illness can change how the whole system responds
Lyme disease can directly affect the nervous system in some people. Persistent symptoms can also leave someone feeling watchful, unsettled or less able to tolerate physical, cognitive or emotional demands.
Pain, disrupted sleep, uncertainty, reduced capacity and repeated symptom flares can interact. The nervous system may become quicker to anticipate difficulty or respond strongly to familiar sensations.
This does not mean that Lyme disease is psychological, that symptoms are imagined or that nervous-system regulation can eliminate an active infection.
It means that the nervous system can be one relevant part of a much broader biological and personal picture.
Body sensations
Pain, dizziness, palpitations or fatigue may become closely associated with fear or anticipation.
Uncertainty
Not knowing when symptoms will change can keep attention focused on possible danger.
Reduced confidence
Repeated setbacks may make everyday activities feel less predictable.
Repeated responses
Patterns of bracing, scanning, avoidance or alarm can become familiar through repetition.
Lyme disease and neuroplasticity
Where neuroplasticity-based practice may fit
Neuroplasticity is the brain and nervous system’s ability to change through learning, experience and repetition.
For someone living with persistent symptoms, neuroplasticity-based practice may help them notice familiar patterns, create more space around symptom-related alarm, respond differently to difficult sensations and build greater confidence in everyday situations.
This is a supportive approach. It does not diagnose Lyme disease, eradicate bacteria, reverse tissue damage or replace medical treatment.
✕prove that symptoms are psychological;
✕mean someone caused their illness;
✕replace antibiotics when they are medically indicated;
✕confirm that an infection has or has not cleared;
✕guarantee symptom reduction or recovery.
The re-origin approach
Support for working with persistent nervous-system patterns
re-origin brings together science-informed neuroplasticity programs, brain-body practices, coaching and community support for nervous-system regulation.
Members can use the platform alongside appropriate medical care to understand repeated patterns, practise steadier responses to difficult sensations and rebuild confidence gradually.
The focus is not on denying the original infection or forcing symptoms away. It is on helping people develop practical ways to work with the nervous system while respecting their health, capacity and current treatment plan.
re-origin is not a Lyme disease diagnostic service, antibiotic treatment or cure.
Understand patterns
Explore how symptoms, attention, stress, uncertainty and repeated responses may interact.
Create more space around alarm
Practise responding to difficult sensations with less immediate fear or urgency.
Build confidence gradually
Use short, repeatable practices that can be adapted around current capacity.
Practise with support
Access structured programs, guided practices, coaching and moderated member communities.
Members should continue working with appropriately qualified healthcare professionals. Individual experiences vary, and no program can guarantee a particular health outcome.
Community
Personal experiences from the re-origin community
These stories describe individual experiences. They are not clinical evidence, do not represent a typical outcome and cannot predict what another person will experience.
Jocelyne’s experience with Lyme disease and persistent symptoms
Post-treatment Lyme disease syndrome
Ben Ahrens and the origins of re-origin
Angela’s experience with mould, Lyme and depression
Autumn’s experience with POTS, Lyme and autoimmune symptoms
Katie Rapkoch, CHPC
Biography & credentials to be confirmed before publication
Katie Rapkoch is the author of this article and has contributed to re-origin’s neuroplasticity education. Her confirmed biography, credentials, photograph and profile link will be added before publication.
Last updated: July 2026 · Last medically reviewed: pending clinical sign-off
The final medical reviewer’s name, qualification and review date will appear here as a separate credited card once an appropriately qualified reviewer has approved the final page.
Related topics
Related symptoms and experiences
Post-treatment Lyme disease syndrome (PTLDS)
Persistent fatigue, pain and cognitive symptoms after recommended Lyme treatment.
Chronic fatigue and ME/CFS
Post-exertional malaise, unrefreshing sleep and a substantial loss of capacity.
POTS and orthostatic intolerance
Dizziness, palpitations and symptoms that worsen when upright.
Chronic pain
Persistent pain, overlapping mechanisms and the wider nervous-system context.
Fibromyalgia
Widespread pain, fatigue, sleep disruption and sensitivity.
Sleep difficulties
Unrefreshing sleep, disrupted sleep and the relationship between rest and capacity.
Questions
Questions about chronic Lyme disease and PTLDS
Is chronic Lyme disease real?
People can experience persistent and disabling symptoms following Lyme disease. “Chronic Lyme disease” is a broad term, however, and is not used consistently. When symptoms continue after documented Lyme disease has received recommended treatment, clinicians may use terms such as PTLDS or prolonged symptoms associated with Lyme disease.
What is post-treatment Lyme disease syndrome?
PTLDS describes a pattern of fatigue, pain, cognitive difficulty or other symptoms that continue for months after recognised Lyme disease has received recommended antibiotic treatment. There is no single test that independently confirms PTLDS, and its underlying mechanisms remain under investigation.
Can symptoms continue after antibiotics?
Yes. Most people improve following recommended treatment, but a minority report prolonged symptoms. Continuing symptoms do not automatically prove that an active infection remains, so medical reassessment may consider several possible explanations.
Does a negative blood test rule out Lyme disease?
Not always. Antibody tests may be negative during the early weeks of infection. Testing becomes more sensitive with time. Diagnosis should consider exposure, symptoms, examination and the timing and type of testing.
Can a positive Lyme test show whether the infection is still active?
Not necessarily. Lyme antibodies can remain detectable for months or years after the infection has been treated. Test results need to be interpreted alongside the person’s symptoms and clinical history.
Can Lyme disease be transmitted sexually?
Current CDC information states that there is no evidence that Lyme disease is transmitted through sexual contact.
Can Lyme disease affect pregnancy?
Untreated Lyme disease during pregnancy can, rarely, affect the placenta or fetus. Prompt assessment and appropriate antibiotic treatment are important. Anyone who is pregnant and suspects Lyme disease should contact a qualified healthcare professional.
Do prolonged antibiotics help PTLDS?
Clinical trials have not shown sustained overall benefit from prolonged antibiotic courses for nonspecific persistent symptoms after recommended Lyme treatment, and longer treatment can cause harm. A clinician should assess possible reinfection, treatment failure or objective complications before deciding whether further antibiotics are appropriate.
Can Lyme disease affect the nervous system?
Yes. Lyme disease can cause recognised neurological complications in some people. Persistent symptoms can also affect sleep, stress responses, confidence and the way sensations are processed. These are different issues and require an individual assessment.
Can neuroplasticity cure chronic Lyme disease?
No program can claim that neuroplasticity cures Lyme disease or eliminates an active infection. Neuroplasticity-based practices may be used as one supportive way of working with nervous-system regulation, repeated alarm responses and confidence alongside appropriate medical care.
Can re-origin treat Lyme disease?
re-origin is not a Lyme disease treatment or diagnostic service. It provides science-informed neuroplasticity programs, brain-body practices, coaching and community support for nervous-system regulation.
Should I stop medical treatment when using re-origin?
No. re-origin should be used alongside appropriate medical care. Do not start, stop or change antibiotics, medication, rehabilitation or other treatment based on this page or the program alone.
Support designed to meet you where you are
Science-informed neuroplasticity programs, practices, coaching, and community for nervous system regulation. Built by people who’ve lived it. Designed to meet you where you are. Carried by community.
Medical disclaimer
The information on this page is provided for educational purposes only. It is not intended to diagnose, treat, cure or prevent any condition and does not replace assessment, diagnosis or treatment from qualified healthcare professionals. Do not start, stop or change medication or treatment based on this page. Seek appropriate medical advice for new, severe, worsening or unexplained symptoms.
References
- Centers for Disease Control and Prevention. How Lyme Disease Spreads. CDC (accessed July 2026). View source
- Centers for Disease Control and Prevention. Signs and Symptoms of Untreated Lyme Disease. CDC (accessed July 2026). View source
- Centers for Disease Control and Prevention. Testing and Diagnosis for Lyme Disease. CDC (accessed July 2026). View source
- Centers for Disease Control and Prevention. Chronic Symptoms and Lyme Disease. CDC (accessed July 2026). View source
- Centers for Disease Control and Prevention. Clinical Care of Lyme Disease. CDC (accessed July 2026). View source
- National Institute of Allergy and Infectious Diseases. Chronic Lyme Disease. NIAID (accessed July 2026). View source
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by IDSA, AAN and ACR: 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. IDSA guideline. View source
- National Institute for Health and Care Excellence. Lyme disease: diagnosis and management. NICE guideline NG95. NICE guidance. View source
- Aucott JN, Yang T, Yoon I, et al. Risk of post-treatment Lyme disease in patients with ideally treated early Lyme disease: a prospective cohort study. International Journal of Infectious Diseases. 2022;116:230–237. Journal source. View source
- Ursinus J, Vrijmoeth HD, Harms MG, et al. Prevalence of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study. The Lancet Regional Health – Europe. 2021;6:100142. Journal source. View source
- Marques A. Persistent Symptoms After Treatment of Lyme Disease. Infectious Disease Clinics of North America. 2022;36(3):621–638. Journal source. View source
- Klempner MS, Hu LT, Evans J, et al. Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease. New England Journal of Medicine. 2001;345:85–92. Journal source. View source
- Berende A, ter Hofstede HJM, Vos FJ, et al. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. New England Journal of Medicine. 2016;374:1209–1220. Journal source. View source
- Fallon BA, Keilp JG, Corbera KM, et al. A Randomized, Placebo-Controlled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy. Neurology. 2008;70:992–1003. Journal source. View source
- Centers for Disease Control and Prevention. Lyme Disease: What You Need to Know. CDC (PDF, accessed July 2026). View source